SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CECONI, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.146
EU - Europa 4.494
AS - Asia 2.316
SA - Sud America 19
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 2
Totale 22.996
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.132
IT - Italia 1.674
CN - Cina 1.408
UA - Ucraina 1.222
TR - Turchia 565
DE - Germania 525
GB - Regno Unito 427
FI - Finlandia 274
SG - Singapore 239
SE - Svezia 175
FR - Francia 67
PL - Polonia 31
ID - Indonesia 19
VN - Vietnam 15
ES - Italia 13
AU - Australia 12
IN - India 12
RU - Federazione Russa 11
BE - Belgio 9
BR - Brasile 9
CZ - Repubblica Ceca 9
GE - Georgia 8
HK - Hong Kong 8
KR - Corea 8
MX - Messico 8
NL - Olanda 8
RO - Romania 7
CH - Svizzera 6
IR - Iran 6
JP - Giappone 6
PT - Portogallo 6
TW - Taiwan 6
AL - Albania 5
CA - Canada 5
EU - Europa 5
IE - Irlanda 5
CL - Cile 4
CO - Colombia 4
AT - Austria 3
GR - Grecia 3
HR - Croazia 3
IL - Israele 3
AM - Armenia 2
BG - Bulgaria 2
LT - Lituania 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
HU - Ungheria 1
MD - Moldavia 1
MM - Myanmar 1
PE - Perù 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 22.996
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.374
Fairfield 2.367
Houston 1.349
Jacksonville 1.347
Ashburn 1.039
Seattle 985
Chandler 887
Ann Arbor 886
Wilmington 799
Cambridge 795
Izmir 432
Nanjing 410
Princeton 349
San Diego 232
Boardman 189
Beijing 146
Singapore 136
Shenyang 135
Milan 123
Nanchang 119
Rome 94
Hebei 81
New York 79
San Mateo 76
Changsha 70
Falls Church 68
Jiaxing 66
Ferrara 62
Tianjin 58
Jinan 57
Mountain View 47
Shanghai 46
Verona 42
Ningbo 39
Zhengzhou 39
Bremen 38
Redwood City 37
London 36
Taizhou 36
Naples 33
Philadelphia 30
Warsaw 30
Norwalk 27
Addison 25
Tappahannock 25
Napoli 24
Indiana 22
Kunming 20
Des Moines 18
Orange 18
Bari 17
Chicago 17
Washington 17
Hangzhou 16
Bologna 15
Lappeenranta 15
Dearborn 14
Dong Ket 14
Florence 14
Genova 14
Guangzhou 14
Palermo 14
Turin 14
Helsinki 13
Jakarta 13
Los Angeles 13
Changchun 11
Kilburn 11
Padova 11
Redmond 11
Brescia 10
Cagliari 9
Torino 9
Brussels 8
Catania 8
Olomouc 8
Tbilisi 8
Yellow Springs 8
Auburn Hills 7
Haikou 7
Lanzhou 7
Pisa 7
Hounslow 6
Hualien City 6
Modena 6
Caserta 5
Como 5
Fuzhou 5
Livorno 5
Monmouth Junction 5
Pozzo Di Gotto 5
Sheffield 5
Siena 5
Taranto 5
Trieste 5
Bacoli 4
Chiswick 4
Frankfurt am Main 4
Genoa 4
Giugliano in Campania 4
Totale 16.904
Salva come PNG Salva come JPEG
Nome #
IL METABOLISMO DEL MIOCARDIO ISCHEMICO IBERNATO E STORDITO: DIFFERENZA TRA NECROSI E APOPTOSI 1.664
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 168
Effects of temperature on myocardial calcium homeostasis and mitochondrial function during ischemia and reperfusion. 154
Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL 147
Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study 143
Enhanced expression and activity of xanthine oxidoreductase in the failing heart. 137
Uric acid and coronary artery disease: An elusive link deserving further attention 133
Guidelines on myocardial revascularization 130
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 130
Prolonged propionyl-L-carnitine pre-treatment of rabbit: biochemical, hemodynamic and electrophysiological effects on myocardium. 129
2015 ESC Guidelines for the diagnosis and management of pericardial diseases The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS) 128
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). 122
A way forward to the elimination of conflict of interest for experts involved in regulatory medicine and guidelines 117
Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy 117
Time course of human atrial natriuretic factor release during cardiopulmonary bypass in mitral valve and coronary artery diseased patients. 114
Third Universal Definition of Myocardial Infarction 113
Is stunning an important component of preconditioning? 112
Abnormalities of left ventricular function in asymptomatic patients with systemic sclerosis using doppler measures of myocardial strain. 112
Postinfarction Left Ventricular Free Wall Rupture: Original Management and Surgical Technique 111
Reduction of oxidative stress by carvedilol: role in maintenance of ischaemic myocardium viability. 111
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes 111
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 111
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals 111
Tumor necrosis factor in congestive heart failure: a mechanism of disease for the new millennium? 110
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation * Developed with the special contribution of the European Heart Rhythm Association. 110
Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression 110
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD 110
Link between chronic obstructive pulmonary disease and coronary artery disease: Implication for clinical practice 109
Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) 109
Effects of endotoxic shock on neuronal NOS and calcium transients in rat cardiac myocytes 109
The combined effect of subcutaneous granulocyte- colony stimulating factor and myocardial contrast echocardiography with intravenous infusion of sulfur hexafluoride on post-infarction left ventricular function, the RIGENERA 2.0 trial: Study protocol for a randomized controlled trial 109
Occurrence of oxidative stress during reperfusion of the human heart. 108
Heart rate reduction with ivabradine prevents the global phenotype of left ventricular remodeling. 108
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation 108
Effects of iloprost (ZK 36374) on glutathione status during ischaemia and reperfusion of rabbit isolated hearts 107
Specific properties and effect of perindopril in controlling the renin-angiotensin system. 107
Relevance of apoptosis in influencing recovery of hibernating myocardium 107
In vitro administration of ergothioneine failed to protect isolated ischaemic and reperfused rabbit heart 107
Incremental exercise using progressive versus constant pedaling rates: A study in cardlac patients 107
null 106
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes (Am Journal of Cardiovasc Drugs (2011) 11:3 (189-98)) 106
null 106
Right heart failure chronically stimulates heat shock protein 72 in heart and liver but not in other tissues. 106
Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE 106
Differences in the effect of angiotensin-converting enzyme inhibitors on the rate of endothelial cell apoptosis: in vitro and in vivo studies 105
Oxygen Free Radicals in Shock 105
Plasma levels of atrial natriuretic factor and urinary excretion of arginine vasopressin and catecholamines in children with congenital heart disease effect of cardiac surgery 104
Revascularization of hibernating myocardium: rate of metabolic and functional recovery and occurrence of oxidative stress. 104
Traditional and new composite endpoints in heart failure clinical trials: Facilitating comprehensive efficacy assessments and improving trial efficiency 104
Oxygen free radicals and myocardial damage: protective role of thiol-containing agents. 103
Changes in oxidative stress and cellular redox potential during myocardial storage for transplantation: Experimental studies 103
Effect of superoxide generation on rat heart mitochondrial pyruvate utilization 103
ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). 103
Selective and specific I f inhibition with ivabradine: New perspectives for the treatment of cardiovascular disease 103
Different outcomes of the reperfused myocardium: insights into the comments of stunning and hibernation. 102
Noradrenaline, atrial natriuretic peptide, bombesin and neurotensin in myocardium and blood of rats in congestive cardiac failure. 102
The ACE-inhibitor Perindoprilat has high selectivity for bradykinin binding sites of human somatic ACE 102
Pathophysiological role of heart rate: from ischaemia to left ventricular dysfunction 102
Secondary Prevention of CAD with ACE Inhibitors: A Struggle Between Life and Death of the Endothelium 102
New insights on myocardial pyridine nucleotides and thiol redox state in ischemia and reperfusion damage 101
Oxygen free radicals and reperfusion injury; the effect of ischaemia and reperfusion on the cellular ability to neutralise oxygen toxicity 101
Potential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarction 101
Metabolic adaptation during a sequence of no-flow and low-flow ischemia. A possible trigger for hibernation. 100
Chromogranin A in heart failure - A novel neurohumoral factor and a predictor for mortality 100
Third universal definition of myocardial infarction 100
Improved exercise tolerance after losartan and enalapril in heart failure: correlation with changes in skeletal muscle myosin heavy chain composition 100
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC 100
Anti-ischemic effect of IVA in isolated rabbit hearts: Modulation of cardiac metabolism 100
Left ventricular dysfunction due to stunning and hibernation in patients. 99
Anti-ischaemic effect of ivabradine 99
Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review 99
Evidence against malondialdehyde bound to cellular constituents in phospholipid peroxidation 99
Protective effect of a prostacyclin-mimetic on the ischaemic-reperfused rabbit myocardium. 98
Myocardial damage during ischaemia and reperfusion. 98
Protective effect of propionyl-L-carnitine against ischaemia and reperfusion-damage. 98
Efficacy of Ivabradine in Combination with Beta-Blocker Versus Uptitration of Beta-Blocker in Patients with Stable Angina 98
Role of A2A receptor in the modulation of myocardial reperfusion damage. 98
Effects of felodipine on the ischemic heart: insight into the mechanism of cytoprotection. 97
Metabolic changes during post-ischaemic reperfusion. 97
Mechanical vs. electrical dyssynchrony for CRTselection in patients with HF 97
One heart, two lungs together forever 97
Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). 97
Activation of the neuroendocrine response in heart failure: adaptive or maladaptive process? 97
Effect of L-carnitine derivatives on heart mitochondrial damage induced by lipid peroxidation. 97
The role of glutathione status in the protection against ischaemic and reperfusion damage: effects of N-acetyl cysteine. 97
Cardioprotection by nisoldipine: role of timing of administration. 96
Skeletal muscle abnormalities in rats with experimentally induced heart hypertrophy and failure. 96
Oxidative stress during myocardial ischaemia and heart failure. 96
The effect of propionyl-L-carnitine on the ischemic and reperfused intact myocardium and on their derived mitochondria. 96
Preventive cardiology: comparisons of European and Italian projects with the Cardiac Units from Emilia Romagna region. A workshop of IACPR/GICR - Emilia Romagna 96
Third Universal Definition of Myocardial Infarction 96
Specific and selective I-f inhibition: expected clinical benefits from pure heart rate reduction in coronary patients 96
Lipid peroxidation in normal pregnancy and preeclampsia 95
The occurrence of oxidative stress during reperfusion in experimental animals and men. 95
The influence of right heart catheterisation on pulmonary arterial pressure in chronic heart failure: relationship to neuroendocrinal changes 95
null 95
The ACE-inhibitor perindoprilat has high selectivity for bradykinin binding sites of human somatic ACE 95
Differential action of ACE inhibitors on the eNOS pathway 95
Future strategies of reverse remodeling prevention of hibernation 95
Ace inhibition with perindopril and markers of atherosclerosis and thrombosis: Results of the pertinent study 95
Totale 12.234
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.268
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.015
Totale 86.283
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.399 881 186 185 803 419 606 454 585 418 577 165 120
2020/20213.361 295 343 198 452 178 362 78 437 76 438 353 151
2021/20222.999 85 374 306 82 107 137 167 151 100 187 262 1.041
2022/20232.315 277 29 78 259 391 382 52 243 315 24 152 113
2023/20241.176 178 166 77 50 66 130 48 31 18 64 56 292
2024/202517 17 0 0 0 0 0 0 0 0 0 0 0
Totale 23.242